These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Lesions sub-diagnostic of endometrioid intra-epithelial neoplasia/atypical hyperplasia: value of morphology and immunohistochemistry in predicting neoplastic outcome. Wyvekens N; Mutter GL; Nucci MR; Kolin DL; Parra-Herran C Histopathology; 2024 Oct; 85(4):579-589. PubMed ID: 38785042 [TBL] [Abstract][Full Text] [Related]
8. Endometrial Intraepithelial Neoplasia (EIN) in endometrial biopsy specimens categorized by the 1994 World Health Organization classification for endometrial hyperplasia. Li XC; Song WJ Asian Pac J Cancer Prev; 2013; 14(10):5935-9. PubMed ID: 24289604 [TBL] [Abstract][Full Text] [Related]
9. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy. Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731 [TBL] [Abstract][Full Text] [Related]
10. BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia. Trabzonlu L; Muezzinoglu B; Corakci A Pathol Oncol Res; 2019 Apr; 25(2):471-476. PubMed ID: 29270778 [TBL] [Abstract][Full Text] [Related]
11. Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers. Niu S; Lucas E; Molberg K; Strickland A; Wang Y; Carrick K; Rivera-Colon G; Gwin K; SoRelle JA; Castrillon DH; Zheng W; Chen H Am J Surg Pathol; 2022 Oct; 46(10):1447-1455. PubMed ID: 35834400 [TBL] [Abstract][Full Text] [Related]
12. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma. Xiong Y; Xiong YY; Zhou YF Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231 [TBL] [Abstract][Full Text] [Related]
14. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia. Vetter MH; Smith B; Benedict J; Hade EM; Bixel K; Copeland LJ; Cohn DE; Fowler JM; O'Malley D; Salani R; Backes FJ Am J Obstet Gynecol; 2020 Jan; 222(1):60.e1-60.e7. PubMed ID: 31401259 [TBL] [Abstract][Full Text] [Related]
15. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias. Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462 [TBL] [Abstract][Full Text] [Related]
16. Endometrioid Tubal Intraepithelial Neoplasia (E-TIN) of the Fallopian Tube: A Case Series. Hecht JL; Lin DI; Garrett L Int J Gynecol Pathol; 2020 Nov; 39(6):552-557. PubMed ID: 31855954 [TBL] [Abstract][Full Text] [Related]
17. PI3K Pathway Effectors pAKT and FOXO1 as Novel Markers of Endometrioid Intraepithelial Neoplasia. Strickland AL; Rivera G; Lucas E; John G; Cuevas I; Castrillon DH Int J Gynecol Pathol; 2019 Nov; 38(6):503-513. PubMed ID: 30256235 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade. Urabe R; Hachisuga T; Kurita T; Kagami S; Kawagoe T; Matsuura Y; Shimajiri S J Obstet Gynaecol Res; 2014 Mar; 40(3):812-9. PubMed ID: 24246002 [TBL] [Abstract][Full Text] [Related]